Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection

2001 ◽  
Vol 77 (3) ◽  
pp. 165-170 ◽  
Author(s):  
Peter Schrenk ◽  
Margit Hatzl-Griesenhofer ◽  
Andreas Shamiyeh ◽  
Wolfgang Waynad
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Cancer Patients ◽  
Axillary Lymph Node ◽  
Axillary Lymph ◽  
Breast Cancer Patients ◽  
Node Dissection ◽  
Node Negative ◽  
Node Negative Breast Cancer

The prognosis of HER2/neu expression in axillary lymph node-negative breast cancer patients

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 9653-9653
Author(s):  
G.-H. Di ◽  
H.-C. Li ◽  
Y.-F. Hou ◽  
J.-S. Lu ◽  
J. Wu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Cancer Patients ◽  
Axillary Lymph Node ◽  
Axillary Lymph ◽  
Breast Cancer Patients ◽  
Node Negative ◽  
Node Negative Breast Cancer

The prognosis of HER2/neu expression in axillary lymph node-negative breast cancer patients

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 9653-9653
Author(s):  
G.-H. Di ◽  
H.-C. Li ◽  
Y.-F. Hou ◽  
J.-S. Lu ◽  
J. Wu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Cancer Patients ◽  
Axillary Lymph Node ◽  
Axillary Lymph ◽  
Breast Cancer Patients ◽  
Node Negative ◽  
Node Negative Breast Cancer

Adherence to post-surgery follow-up assessment and its association with sociodemographic and disease characteristics in patients with breast cancer in China.

2020 ◽  
Vol 38 (15_suppl) ◽  
pp. e19232-e19232
Author(s):  
Ran Feng ◽  
Jingfeng Jing ◽  
Haibo Yang ◽  
Xiaojun Zhang ◽  
Ming Li ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Cancer Patients ◽  
Axillary Lymph Node ◽  
Insurance Coverage ◽  
Axillary Lymph ◽  
Breast Cancer Patients ◽  
Node Dissection ◽  
Post Surgery

e19232 Background: The incidence of breast cancer has increased more than 30% in the past decades in China. Epidemiological studies based on international and Chinese data have showed that breast cancer is the most common in female malignant tumors. Breast cancer patients with early breast cancer have better survival, lower recurrence and metastasis rate due to early diagnosis and improved treatment. As an important element in the comprehensive management of breast cancer patients, follow-up can eliminate treatment-related complications, detect recurrence and metastasis as early as possible, and improve mental health and quality of life. It is increasingly recognized as a distinct phase of cancer care. However, follow-up adherence after breast surgery has not been studied in China. The aim of this study is to investigate the loss of follow-up after breast cancer surgery and its association with patients', tumor and treatment characteristics. Methods: A total of 711 patients underwent surgical treatment in Shanxi Bethune Hospital from March 2012 to May 2018 were included in this study. Baseline socio-demographic, tumor, and treatment characteristics were obtained from the hospital electronic medical records. The post-surgery follow-up was reviewed and assessed from the patients’ follow-up examination record. Factors associated with the first three-year follow-up was evaluated using logistic regression analysis. Results: The annual follow-up rate after surgery decreased gradually from 67.1% at the 1st year, 60.2% at the 3rd year to 51.9% at the 4th year, and 43.5% at the 5th year. Loss of follow-up during the first three years after surgery was significantly associated with older age >65 years(OR=2.34, 95% CI:1.14-4.82), lower medical insurance coverage(OR=4.26, 95%CI:1.77-10.25), axillary lymph node dissection(OR=2.52, 95%CI:1.39-4.55), no chemotherapy(OR=3.55, 95% CI:1.87-6.75) and no radiotherapy(OR=3.85, 95%CI:2.11-7.03). Conclusions: This study indicated that the annual follow-up rate after curative surgery for breast cancer survivors decreased significantly within five years, and that the risk of poor adherence to follow-up examinations was significantly increased in patients aged over 65 years with lower medical insurance coverage, having extensive axillary lymph node dissection, and lack of systematic treatments. These results suggest potential for improving adherence to follow-up in higher-risk subgroups and help clinicians to develop tailored patient management.

Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: A long term follow-up analysis

2004 ◽  
Vol 88 (1) ◽  
pp. 4-7 ◽  
Author(s):  
Hans Torrenga ◽  
Hans Fabry ◽  
Joost R.M. van der Sijp ◽  
Paul J. van Diest ◽  
Rik Pijpers ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Axillary Lymph ◽  
Breast Cancer Patients ◽  
Node Dissection ◽  
Node Negative ◽  
Node Negative Breast Cancer ◽  
Long Term Follow Up

Omission of axillary lymph node dissection for clinically node negative early-stage breast cancer patients

Breast Cancer ◽  
2014 ◽  
Vol 22 (6) ◽  
pp. 657-663 ◽  
Author(s):  
Reiko Kobayashi ◽  
Kenshiro Shiraishi ◽  
Satoru Iwase ◽  
Kuni Ohtomo ◽  
Keiichi Nakagawa
Keyword(s):  
Breast Cancer ◽  
Lymph Node ◽  
Cancer Patients ◽  
Axillary Lymph Node Dissection ◽  
Axillary Lymph Node ◽  
Early Stage ◽  
Axillary Lymph ◽  
Breast Cancer Patients ◽  
Node Dissection ◽  
Node Negative
Sign in / Sign up

Export Citation Format

Share Document